Kernel Capital invests in Biocroi

The majority of the funding, €500,000, was provided by Kernel's €10m Bank of Ireland Medtech Accelerator Fund, while the remainder comes from Enterprise Ireland and private investors.

Kernel was attracted to the firm's development through collaborative partnerships with tier one international pharmaceutical companies and instrument suppliers.

Company
Biocroí is a spin-out from Trinity College Dublin and has developed a patented technology around multiwell plates used in high content screening and analysis cell-based assays. Founded in 2009, Biocroí develops its technology through formal research collaboration with pharmaceutical companies and international instrument suppliers.

People
Orla Rimmington is operations director at Kernel Capital and Jim Walsh will join the board of Biocroí as a non-executive director.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Early-stage
• Healthcare
• Ireland